GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
47.18
-0.14 (-0.30%)
At close: Nov 14, 2025, 4:00 PM EST
47.19
+0.01 (0.02%)
After-hours: Nov 14, 2025, 7:57 PM EST
GSK Employees
GSK plc had 68,629 employees as of December 31, 2024. The number of employees decreased by 1,583 or -2.25% compared to the previous year.
Employees
68,629
Change (1Y)
-1,583
Growth (1Y)
-2.25%
Revenue / Employee
$630,016
Profits / Employee
$107,608
Market Cap
94.33B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 68,629 | -1,583 | -2.25% |
| Dec 31, 2023 | 70,212 | 812 | 1.17% |
| Dec 31, 2022 | 69,400 | -20,696 | -22.97% |
| Dec 31, 2021 | 90,096 | -3,970 | -4.22% |
| Dec 31, 2020 | 94,066 | -5,371 | -5.40% |
| Dec 31, 2019 | 99,437 | 3,947 | 4.13% |
| Dec 31, 2018 | 95,490 | -2,972 | -3.02% |
| Dec 31, 2017 | 98,462 | -838 | -0.84% |
| Dec 31, 2016 | 99,300 | -1,955 | -1.93% |
| Dec 31, 2015 | 101,255 | 3,334 | 3.40% |
| Dec 31, 2014 | 97,921 | -1,530 | -1.54% |
| Dec 31, 2013 | 99,451 | -37 | -0.04% |
| Dec 31, 2012 | 99,488 | 2,099 | 2.16% |
| Dec 31, 2011 | 97,389 | 928 | 0.96% |
| Dec 31, 2010 | 96,461 | -3,452 | -3.46% |
| Dec 31, 2009 | 99,913 | 910 | 0.92% |
| Dec 31, 2008 | 99,003 | -4,480 | -4.33% |
| Dec 31, 2007 | 103,483 | 788 | 0.77% |
| Dec 31, 2006 | 102,695 | 1,967 | 1.95% |
| Dec 31, 2005 | 100,728 | 709 | 0.71% |
| Dec 31, 2004 | 100,019 | -900 | -0.89% |
| Dec 31, 2003 | 100,919 | -3,580 | -3.43% |
| Dec 31, 2002 | 104,499 | -2,971 | -2.76% |
| Dec 31, 2001 | 107,470 | -47 | -0.04% |
| Dec 31, 2000 | 107,517 | -1,524 | -1.40% |
| Dec 31, 1999 | 109,041 | -7,780 | -6.66% |
| Dec 31, 1998 | 116,821 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GSK News
- 8 days ago - GlaxoSmithKline India reports higher second-quarter profit on specialty medicine growth - Reuters
- 16 days ago - GSK plc (GSK) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - GSK Upgrades 2025 Financial Outlook, CEO Says Positioned Well For 2026 - Benzinga
- 16 days ago - GSK Raises Guidance After Sales, Earnings Growth - WSJ
- 16 days ago - GSK raises 2025 sales forecast after strong growth in specialty medicines - Reuters
- 21 days ago - GSK shares fall as narrow approval of blood cancer drug limits US relaunch - Reuters
- 22 days ago - FTSE 100 Index shares to watch: HSBC, Standard Chartered, Haleon, GSK - Invezz
- 22 days ago - Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma - Business Wire